CompletedNot Applicable

Mivacurium 0.2 mg/kg in Young (18 - 40 Years) and Elderly (= 80 Years) Patients

Denmark70 participantsStarted 2022-09-30

Plain-language summary

The aim of this study is to determine the onset time, duration of action and effect on intubation conditions of mivacurium 0.2 mg/kg in elderly patients with age ≥ 80 years and in young patients aged 18 - 40 years.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patients ≥ 80 or ≥ 18 to ≤ 40 years of age
✓. Informed consent
✓. Scheduled for elective surgery under general anaesthesia (expected duration of anaesthesia \> 1 hour) with intubation and use of mivacurium
✓. American Society of Anesthesiologists (ASA) physical status classification I to III
✓. Can read and understand Danish

Exclusion criteria

✕. Known allergy to mivacurium
✕. Neuromuscular disease that may interfere with neuromuscular monitoring
✕. Indication for rapid sequence induction
✕. Surgery in the prone position
✕. Known butyrylcholinesterase deficiency

What they're measuring

Onset time

Timeframe: within 10 minutes after administration of mivacurium

Trial details

NCT IDNCT05558137

SponsorMatias Vested

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-05-22

View on ClinicalTrials.gov More Onset Time of Mivacurium, Duration of Action of Mivacurium trials